An Overview of Lipoprotein Metabolism

The Impact of Structural Heterogeneity
  • James Shepherd
  • Christopher J. Packard
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)


Each of the conventionally defined lipoprotein classes in human plasma can be divided into particle subpopulations differing in their lipid and apoprotein content. Such structural heterogeneity generates diversity in the function and metabolic potential of the particles whose clinical significance has recently been emphasised in a number of kinetic studies. The present short overview highlights current developments in this area.


High Density Lipoprotein Lipoprotein Metabolism Familial Hypercholesterolemia High Density Lipoprotein Particle Large VLDL 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alaupovic, P., 1984, The physicochemical and immunological heterogeneity of human plasma high density lipoproteins, in: Clinical and Metabolic Aspects of High Density Lipoproteins (N. E. Miller and G. J. Miller, eds.), Elsevier, Amsterdam, pp. 1–46.Google Scholar
  2. Atmeh, R. F., Shepherd, J., and Packard, C. J., 1983, Subpopulations of apolipoprotein AI in human high density lipoproteins: Their metabolic properties and response to drug therapy, Biochim. Bio -phys. Acta 751:175–188.Google Scholar
  3. Berman, M., Hall, M., Levy, R. I., Eisenberg, S., Bilheimer, D. W., Phair, R. D., and Goebel, R. H., 1978, Metabolism of apo B and apo C lipoproteins in man: Kinetic studies in normal and hyperlipoproteinemic subjects, J. Lipid Res. 19:38–56.Google Scholar
  4. Brewer, H. B., 1981, Current concepts of the molecular structure and metabolism of human apolipo -proteins and lipoproteins, Clin. Wochenschr. 59:1023–1035.CrossRefGoogle Scholar
  5. Cheung, M., and Albers, J. J., 1982, Distribution of high density lipoprotein particles with different apoprotein composition: Particles with AI and AII and particles with AI but no AII, J. Lipid Res. 23:747–753.Google Scholar
  6. Hammond, M. G., Mengel, M. C., Warmke,G. L., and Fisher, W. P., 1977, Macromoleculardispersion of human plasma LDL in hyperlipoproteinemia, Metabolism 26:1231–1242.PubMedCrossRefGoogle Scholar
  7. Kostner, G. M., and Alaupovic, P., 1972, Studies on the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occuring in the high density lipoproteins of human plasma, Biochemistry 11:3419–3428.PubMedCrossRefGoogle Scholar
  8. Krauss, R. M., and Burke, D. J., 1982, Identification of multiple subclasses of plasma LDL in normal humans, J. Lipid Res. 23:97–104.Google Scholar
  9. Mahley, R. W Innerarity, T. L., 1983, Lioprotein receptors and cholesterol homeostasis, Biochim. Biophys. Acta 737:197–222.PubMedGoogle Scholar
  10. Musliner, T. A., Giotas, C., and Krauss, R. M., 1986, Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects, Arteriosclerosis 6:79–87.PubMedCrossRefGoogle Scholar
  11. Packard, C. J., Munro, A., Lorimer, A. R., Gotto, A. M., and Shepherd, J., 1984, Metabolism of apolipoprotein B in large triglyceride rich VLDL of normal and hypertriglyceridaemic subjects, J. Clin. Invest. 74:2178–2192.CrossRefGoogle Scholar
  12. Patsch, J. R., Prasad, S., Gotto, A. M., and Bengtsson-Olivecrona, G., 1984, Postprandial lipemia. A key for the conversion of HDL2 into HDL3 by hepatic lipase, J. Clin. Invest. 74:2017–2023.CrossRefGoogle Scholar
  13. Schaefer, E. J., Zech, L. A., Jenkins, L. L., Bronzert, T. J., Rubacaba, E. A., Lindgren, F. J., Aamodt, R. L., and Brewer, H. B., 1982, Human apolipoprotein AI and AII metabolism, J. Lipid Res. 23:850–858.Google Scholar
  14. Shepherd, J., and Packard, C. J., 1984, High density lipoprotein apolipoprotein metabolism, in: Clinical and Metabolic Aspects of High Density Lipoproteins (N. E. Miller and G. J. Miller, eds.), Elsevier, Amsterdam, pp. 247–274.Google Scholar
  15. Shepherd, J., Packard, C. J., Patsch, J. R., Gotto, A. M., and Taunton, O. D., 1978, Metabolism of apolipoprotein AI and AII and its influence on the high density lipoprotein subfraction distribution in males and females, Eur. J. Clin. Invest. 8:115–120.CrossRefGoogle Scholar
  16. Shepherd, J., Packard, C. J., Stewart, J. M., Atmeh, R. F., Clark, R. S., Boag, D. E., Carr, K., Lorimer, A. R., Ballantyne, D., Morgan, H. G., and Lawrie, T. D. V., 1984, Apolipoprotein A and B (Sf 100–400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects, J. Clin. Invest. 74:2164–2177.CrossRefGoogle Scholar
  17. Teng, B., Thompson, G. R., and Sniderman, A. D., 1983, Composition and distribution of LDL fractions in hyperapobetalipoproteinemia, normolipidemia and familial hypercholesterolemia, Proc. Natl. Acad. Sci. U.S.A. 80:6662–6665.CrossRefGoogle Scholar
  18. Weisgraber, K. H.Mahley, R. W., 1980, Subfractionation of human high density lipoproteins by heparin-sepharose affinity chromatography, J. Lipid Res. 21:316–325.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • James Shepherd
    • 1
  • Christopher J. Packard
    • 1
  1. 1.Royal InfirmaryUniversity Department of Pathological BiochemistryGlasgowScotland

Personalised recommendations